The abstract is read at the publisher; the summary is JClub's.
Natural typhoid fever in a Dhaka, Bangladesh cohort is linked to higher risk of recurrent, blood-culture–confirmed typhoid, with an adjusted hazard ratio of 3.7 (95% CI 1.8–7.9).
- Why it matters: Transmission models and vaccine policy need estimates of how much naturally acquired typhoid protects against later episodes, but evidence for recurrent disease is limited.
- What they did: In a cluster-randomized typhoid conjugate vaccine trial in Dhaka, index blood-culture–confirmed patients and 1:4 matched community controls were followed up to 6 years; recurrent episodes were defined as >30 days after onset and/or different antimicrobial resistance profiles, and stratified Cox models estimated hazard ratios.
- The result: Using community-based controls, recurrent episodes were 13 among 940 index cases versus 12 among 3760 controls (incidence 741 vs 158 per 100,000 person-years; P < .001), but with facility-based controls to reduce healthcare utilization bias the association disappeared (aHR 1.5, 95% CI 0.8–2.8; P = .160).
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.